Immunofoco Presents Preclinical Data for In Vivo CAR T Candidate IMV102 at AACR 2026
Immunofoco presented new preclinical data for its in vivo BCMA-targeting CAR T candidate IMV102 at the AACR Annual Meeting 2026, showing durable tumor control and favorable safety in multiple myeloma models.